Table 1.
Details and characteristics of CMV-infected patients with PSS
| Case | Sex | Unilateral/Bilateral | Age at the clinic visit | Age at the first onset | Frequency of attack (n/year) | Peak IOP | GC dependence | Anti-HCMV IgG (s/co) | CMV (copies/ mL) |
Response to antiviral therapy | CMV genotype |
| 1 | Male | Uni/OS | 54 | 51 | 1 | 46 | – | 1.5 | 2213 | Complete control | gB 1 |
| 2 | Male | Uni/OD | 32 | 29 | 3 | 45 | + | 0.59 | 15 311 | Poor control | gB 1 |
| 3 | Male | Uni/OD | 50 | 49 | 3 | 50 | + | 1.06 | 10 965 | Poor control | gB 1 |
| 4 | Male | Uni/OD | 42 | 38 | 1 | 50 | + | 2.39 | 28 510 | Poor control | gB 1 |
| 5 | Male | Uni/OS | 31 | 25 | 2 | 50 | – | 0.34 | 473 151 | Complete control | gB 1 |
| 6 | Male | Bi/OS | 62 | 56 | 2 | 50 | + | 0.76 | 2 585 235 | Complete control | gB 1 |
| 7 | Male | Uni/OD | 51 | 46 | 1 | 60 | – | 0.27 | 181 970 | Complete control | gB 1 |
| 8 | Female | Uni/OD | 28 | 25 | 1 | 46 | + | 0.28 | 142 889 | Complete control | gB 1 |
| 9 | Male | Uni/OS | 40 | 30 | 1 | 41 | – | 0.67 | 346 737 | Poor control | gB 1 |
| 10 | Male | Uni/OD | 31 | 22 | 1 | 48 | + | 2.29 | 307 256 | Poor control | gB 1 |
| 11 | Male | Uni/OS | 36 | 34 | 1 | 43 | + | 0.24 | 7 852 356 | Poor control | gB 1 |
| 12 | Female | Bi/OD | 37 | 31 | 1 | 45 | + | 0.27 | 407 380 | Complete control | gB 3 |
| 13 | Male | Uni/OS | 55 | 45 | 2 | 52 | – | 0.24 | 301 995 | Poor control | gB 3 |
| 14 | Male | Bi/OD | 65 | 64 | 2 | 48 | – | 1.49 | 38 238 | Poor control | gB 3 |
Bi, bilateral; CMV, cytomegalovirus; gB, glycoprotein B; GC-dependence, glucocorticoids-dependence; HCMV, human cytomegalovirus; IOP, intraocular pressure; OD, right eye; OS, left eye; PSS, Posner-Schlossman syndrome; Uni, unilateral.